Hims & Hers shares surge after reports of a Wegovy partnership with Novo Nordisk, highlighting telehealth’s growing role in the booming obesity drug market.
A key FDA vaccine official is leaving the agency, raising questions about regulatory leadership, vaccine oversight, and the ...
China approves Pfizer’s GLP-1 weight-loss drug, expanding competition in the booming obesity treatment market and highlighting rising metabolic health concerns.
Gene Therapy Meets Regulatory Reality: The FDA–uniQure Clash Over a Promising Huntington’s Treatment
The FDA’s dispute with biotech firm uniQure over Huntington’s gene therapy highlights growing tensions between innovation, ...
Balcony solar systems are quietly transforming clean energy access. Discover how plug-in solar works, its legal challenges, ...
A new U.S. autism research panel is examining potential causes of autism, sparking debate over science, policy, and the ...
Bayer’s $7.25B Roundup settlement gains initial approval in Missouri, potentially resolving thousands of cancer lawsuits tied to glyphosate exposure.
Autism researchers form an independent panel to defend evidence-based science amid controversy over changes to the U.S. federal autism advisory committee.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results